- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Esaote unveils new ultrasound unit
Ultrasound developer Esaote, based in Genoa, Italy, introduced a new premium ultrasound device at the RSNA show. Technos is designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, and completes Esaote’s radiology and
Ultrasound developer Esaote, based in Genoa, Italy, introduced a new premium ultrasound device at the RSNA show. Technos is designed for abdominal, ob/gyn, vascular, small parts, breast, and urology imaging, and completes Esaotes radiology and shared service markets product line. The unit carries a fully digital beamformer and proprietary microchip circuitry, as well as new probe technology that maximizes the lateral resolution of Technos wideband multifrequency transducers. Technos combines color Doppler and power Doppler technology, and runs on a Windows NT operating system.
In other Esaote news, the company celebrated the sale of its 500th dedicated MRI system, which it has achieved through sales of both Artoscan and E-Scan, an open-style, 0.2-tesla MRI scanner dedicated to orthopedic studies. E-Scan was cleared by the Food and Drug Administration in June (SCAN 6/23/99).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
